Honestly, at this rate I think nothing will happen until late Q3 2015 through early 2016. Here is why.....
Consider that the FDA status quo exist chances are the next drug to be approved will take atleast another 6-12 months to be approved. Furthermore, over that time it looks like Folican sales will for 2015 will be between 8-12 Million. So during this time dillution will occur. Short of an approval or partner this stock price will be stuck between 2-3.
This stock has been a waiting game since 2011. The growth has been good but not great compared to other bios trading to similar prices 2 through 4 years ago.
Dr Odiddi has mislead us interms of his time frames. If you look at his prior interviews ranging back to 2011 some of his answers to questions such as partnerships, drug approvals, progress etc has seen answers to these questions with phrases "near-term" "soon" "agressively seeking partners" etc.
I am not saying he is lieing but he definitely mislead in those words. These words date back to 2011. We have had some progress but not the way he packaged it. Our only partner is Par, and 1 drug approval. If you where excited about this company in 2011 you have surely been disapointed, unless you traded the swings.
I am hoping 2015 is the year we see real sustainable gains. But since I am a Mets fan I always find myself saying this year is the year and than I am disapointed as usual. But I would be satisfied if this company finishes with a stock price of 8 bucks in 2015. Is that to hard? For this company based on history that seems to be the case so.
News 
Market Data 
Discover 
AI
